NasdaqGS:OFIX

Stock Analysis Report

Executive Summary

Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and therapies worldwide.

Snowflake

Fundamentals

Flawless balance sheet with moderate growth potential.


Similar Companies

Share Price & News

How has Orthofix Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-2.8%

NasdaqGS:OFIX

0.5%

US Medical Equipment

-0.02%

US Market


1 Year Return

-5.3%

NasdaqGS:OFIX

9.9%

US Medical Equipment

1.6%

US Market

OFIX underperformed the Medical Equipment industry which returned 9.7% over the past year.

OFIX underperformed the Market in United States of America which returned 1.9% over the past year.


Share holder returns

OFIXIndustryMarket
7 Day-2.8%0.5%-0.02%
30 Day-2.6%0.09%2.7%
90 Day-3.6%2.0%1.4%
1 Year-5.3%-5.3%10.8%9.9%3.8%1.6%
3 Year16.1%16.1%69.0%63.9%45.2%35.8%
5 Year62.9%62.9%136.2%109.3%61.8%44.1%

Price Volatility Vs. Market

How volatile is Orthofix Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Orthofix Medical undervalued based on future cash flows and its price relative to the stock market?

13%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

Orthofix Medical's share price is below the future cash flow value, but not at a moderate discount (< 20%).

Orthofix Medical's share price is below the future cash flow value, but not at a substantial discount (< 40%).


Price Based on Earnings

Orthofix Medical is overvalued based on earnings compared to the US Medical Equipment industry average.

Orthofix Medical is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

Orthofix Medical is poor value based on expected growth next year.


Price Based on Value of Assets

Orthofix Medical is good value based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Orthofix Medical expected to perform in the next 1 to 3 years based on estimates from 6 analysts?

56.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Orthofix Medical's revenue is expected to grow by 6.9% yearly, however this is not considered high growth (20% yearly).

Orthofix Medical's earnings are expected to grow significantly at over 20% yearly.

Orthofix Medical's revenue growth is positive but not above the United States of America market average.

Orthofix Medical's earnings growth is expected to exceed the United States of America market average.

Orthofix Medical's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Orthofix Medical will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Orthofix Medical performed over the past 5 years?

62.2%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Orthofix Medical has delivered over 20% year on year earnings growth in the past 5 years.

Orthofix Medical's 1-year earnings growth is negative, it can't be compared to the 5-year average.

Orthofix Medical's 1-year earnings growth is negative, it can't be compared to the US Medical Equipment industry average.


Return on Equity

Orthofix Medical has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

Orthofix Medical used its assets less efficiently than the US Medical Equipment industry average last year based on Return on Assets.


Return on Capital Employed

Orthofix Medical's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is Orthofix Medical's financial position?


Financial Position Analysis

Orthofix Medical is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Orthofix Medical's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Orthofix Medical has no debt.

Orthofix Medical has no debt compared to 5 years ago when it was 6.8%.

Orthofix Medical has no debt, it does not need to be covered by operating cash flow.

Orthofix Medical has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

High level of physical assets or inventory.

Orthofix Medical has no debt, it does not need to be covered by short term assets.


Next Steps

Dividend

What is Orthofix Medical's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Orthofix Medical's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Orthofix Medical's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Orthofix Medical has not reported any payouts.

Unable to verify if Orthofix Medical's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Orthofix Medical has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Orthofix Medical's salary, the management and board of directors tenure and is there insider trading?

6.2yrs

Average management tenure


CEO

Brad Mason (65yo)

6.5yrs

Tenure

US$5,891,448

Compensation

Mr. Bradley R. Mason, also known as Brad , has been the Chief Executive Officer and President of Orthofix Inc. since March 13, 2013. Mr. Mason has been the Chief Executive Officer and President of Orthofix ...


CEO Compensation Analysis

Brad's remuneration is higher than average for companies of similar size in United States of America.

Brad's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


Management Age and Tenure

6.2yrs

Average Tenure

54yo

Average Age

The average tenure for the Orthofix Medical management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

4.8yrs

Average Tenure

61yo

Average Age

The tenure for the Orthofix Medical board of directors is about average.


Insider Trading

Orthofix Medical individual insiders have only sold shares in the past 3 months.


Recent Insider Transactions

SellUS$295,87429 Aug 19
Bradley Mason
EntityIndividual
Role
Chief Executive Officer
President
Shares5,805
Max PriceUS$50.97
SellUS$253,36606 Nov 18
Luke Faulstick
EntityIndividual
Shares4,150
Max PriceUS$61.72

Ownership Breakdown


Management Team

  • Brad Mason (65yo)

    President

    • Tenure: 6.5yrs
    • Compensation: US$5.89m
  • Jim Ryaby (60yo)

    Chief Scientific Officer

    • Tenure: 6.2yrs
  • Dan Yarbrough

    Vice President of Investor Relations

    • Tenure: 0yrs
  • Mike Finegan (55yo)

    Chief Strategy Officer

    • Tenure: 6.3yrs
    • Compensation: US$1.31m
  • Brad Niemann (49yo)

    Consultant

    • Tenure: 7.6yrs
    • Compensation: US$1.39m
  • Davide Bianchi (54yo)

    President of Global Extremities

    • Tenure: 6.2yrs
    • Compensation: US$1.32m
  • Kim Elting (54yo)

    Chief Legal & Administrative Officer

    • Tenure: 1.9yrs
    • Compensation: US$1.64m
  • Doug Rice (53yo)

    CFO & Chief Accounting Officer

    • Tenure: 4.4yrs
    • Compensation: US$1.52m
  • Jill Mason

    Chief Ethics & Compliance Officer

    • Tenure: 3.2yrs
  • Tim McGuire

    Chief Information Officer

    • Tenure: 2.7yrs

Board Members

  • Ron Matricaria (76yo)

    Chairman

    • Tenure: 5.5yrs
    • Compensation: US$449.99k
  • Brad Mason (65yo)

    President

    • Tenure: 6.5yrs
    • Compensation: US$5.89m
  • Lilly Marks (71yo)

    Director

    • Tenure: 4.3yrs
    • Compensation: US$224.95k
  • Jim Hinrichs (51yo)

    Director

    • Tenure: 5.4yrs
    • Compensation: US$239.95k
  • Alex Lukianov (63yo)

    Independent Director

    • Tenure: 2.8yrs
    • Compensation: US$224.95k
  • John Sicard (56yo)

    Independent Director

    • Tenure: 1.5yrs
    • Compensation: US$730.59k
  • Maria Sainz (53yo)

    Director

    • Tenure: 6.8yrs
    • Compensation: US$234.95k
  • Mike Paolucci (59yo)

    Director

    • Tenure: 3.5yrs
    • Compensation: US$234.95k

Company Information

Orthofix Medical Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Orthofix Medical Inc.
  • Ticker: OFIX
  • Exchange: NasdaqGS
  • Founded: 1987
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$962.983m
  • Shares outstanding: 19.03m
  • Website: https://www.orthofix.com

Number of Employees


Location

  • Orthofix Medical Inc.
  • 3451 Plano Parkway
  • Lewisville
  • Texas
  • 75056
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
OFIXNasdaqGS (Nasdaq Global Select)YesCommon SharesUSUSDApr 1992
OM2DB (Deutsche Boerse AG)YesCommon SharesDEEURApr 1992

Biography

Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through four segments: Bone Growth Therapies, Spinal Implants, Biologics, and ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/18 23:42
End of Day Share Price2019/09/18 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.